Analyzing blood biomarkers in patients with Parkinson's disease
Serum Biomarkers in Parkinson's Disease at Different Stages
This study is testing blood samples from people with Parkinson's disease to see how certain markers can help us understand the disease's progression and what happens in the body at different stages.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Roma) |
| Trial ID | NCT05769699 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the clinical characteristics of patients with Parkinson's disease at various stages of the condition. It involves measuring biomarkers related to peripheral neurodegeneration, synaptic function, and inflammation through blood samples. By evaluating these biomarkers, the study seeks to enhance understanding of the disease's progression and its underlying mechanisms.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-80 diagnosed with idiopathic Parkinson's disease.
Not a fit: Patients who are pregnant or have inflammatory or autoimmune diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and monitoring strategies for Parkinson's disease.
How similar studies have performed: While similar studies have explored biomarkers in Parkinson's disease, this specific approach to measuring multiple types of biomarkers at different disease stages is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria; * Age: 18-80 years; * Signature of informed consent to participate in this study Exclusion criteria. * Women pregnant * Inflammatory or autoimmune diseases
Where this trial is running
Roma
- Flavia Torlizzi — Roma, Italy (Recruiting)
Study contacts
- Study coordinator: Giulia Di Lazzaro, MD
- Email: giulia.dilazzaro@policlinicogemelli.it
- Phone: 0630154303
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.